C
Power Law company profile
Caribou Biosciences
Biotech & Life Sciences · Berkeley, United States · Founded 2011 · IPO 2021 Unicorn
Valuation
$78M
Market cap · Apr/2026
Revenue
$11M
Latest reported FY
Global footprint
Where Caribou Biosciences has talent and traffic
Web traffic by country
7.6K
monthly visits
across markets
across markets
🇺🇸 United States57.9%
🇨🇦 Canada21.1%
🇬🇧 United Kingdom15.8%
🇮🇳 India3.9%
🇯🇵 Japan1.3%
Patent intelligence
$98M patent portfolio · 35 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.
Estimated portfolio value
$98M
125.1% of market cap · 20.7× smaller than top peer Ablynx ($2B)
35 active patent families
Where Caribou Biosciences innovates
Molecular biologyNucleic acidBioinformaticsCAR - Chimeric antigen receptorPolynucleotide
Tech-focus vs peers
Where Caribou Biosciences concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Caribou Biosciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Caribou Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.